Immediate Impact

67 standout
Sub-graph 1 of 24

Citing Papers

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
2025 Standout
1 intermediate paper

Works of Eshan Senanayake being referenced

Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery
2014

Author Peers

Author Last Decade Papers Cites
Eshan Senanayake 122 146 87 28 366
Donald C. Finlayson 108 142 86 30 348
Marco Pavesi 87 197 96 32 410
Andrew D. Jung 74 224 73 32 366
Mustafa Şırlak 112 164 89 34 386
Konstantinos Stamoulis 104 109 80 31 360
Alireza Yaghoubi 155 66 63 29 383
Suzanne Kats 202 162 52 33 389
Alexander Nagrebetsky 114 134 40 22 393
Srikanth Sridhar 55 93 93 27 374
Ömer Faruk Doğan 156 195 97 52 377

All Works

Loading papers...

Rankless by CCL
2026